Nav: Home

Experts call for strategies to address public health crisis of opioid, ID epidemics

April 04, 2019

Citing the spread of infections linked to rising rates of opioid use across the country including HIV, viral hepatitis, skin and soft tissue infections, bone and joint infections and endocarditis, an article published in the Journal of Infectious Diseases calls on the federal government to support coordinated and strengthened responses by infectious diseases and substance use specialists. The article, by a team of authors from the University of Maryland School of Medicine, and from the National Institute of Allergy and Infectious Diseases that includes NIAID Director Dr. Anthony Fauci, notes that opioid use has climbed since the late 1990s, leading to increased use of injecting drugs. By 2016, the authors note, injecting drug use was linked to 13% of new HIV diagnoses and the majority of new hepatitis C infections.

The article notes that infectious disease physicians confronting outbreaks of infections linked to injection drug use increasingly find themselves on the frontlines of the nation's opioid epidemic, and must be equipped to recognize, refer, and treat substance use disorders. In turn, the authors recommend that providers of substance use disorder responses, including mental health professionals, nurses and social workers, be prepared to screen clients for infections, and to refer those at risk to programs providing sterile needles and syringes and other supports to reduce the risk of infection. Limited numbers of providers in both fields, as well as a lack of sterile needle and syringe programs, the authors note, exacerbate the challenges providers face in addressing the growing crisis.

The authors call for investments by the federal government ensuring the expansion of evidence-based interventions, and support for the needed workforce.

The Infectious Diseases Society of America and the HIV Medicine Association also continue to call on Congress and the administration to ensure the resources and workforce needed to reverse climbing rates of infectious diseases fueled by the opioid epidemic. We have supported the President's request for Congress to provide a minimum of $58 million for U.S. Centers for Disease Control and Prevention to support surveillance, prevention, detection and linkages to care to address the full range of infectious diseases associated with substance use disorders, and support collaboration with state and local health departments, health care facilities, and providers in these responses. In addition, we urge Congress to fund the Loan Repayment for Substance Use Treatment Disorder Treatment Workforce Program at a minimum of $25 million as recommended in the SUPPORT Act and have urged the Health and Human Resources Administration to include infectious diseases and HIV physicians who diagnose and treat infections associated with substance use in programs providing education loan repayment, including by designating Ryan White-funded clinics as eligible National Health Service Corps sites.

We will continue to urge support for evidence-based, innovative and responsive care models and for addressing the challenges faced by the workforce that will be essential to ending the impacts of the opioid crisis.
-end-


Infectious Diseases Society of America

Related Hepatitis Articles:

Hepatitis C increasing among pregnant women
Hepatitis C infections among pregnant women nearly doubled from 2009-2014, likely a consequence of the country's increasing opioid epidemic that is disproportionately affecting rural areas of states including Tennessee and West Virginia.
WHO's Global Hepatitis Report sets baseline to eliminate viral hepatitis by 2030
The World Hepatitis Alliance today welcomes the publication of the first-ever Global Hepatitis Report by the World Health Organization (WHO), which includes new data on the prevalence and global burden of viral hepatitis.
Elimination of viral hepatitis by 2030: What's needed and how do we get there?
This first European Action Plan provides an important driver to aid countries in their fight against viral hepatitis, to which ECDC had the opportunity to contribute directly.
Discovery of new Hepatitis C virus mechanism
Researchers at Osaka University, Japan uncovered the mechanisms that suppress the propagation of the hepatitis C virus with the potential of improving pathological liver conditions.
Is Europe ready to eliminate viral hepatitis?
Currently, Europe records around 57,000 newly diagnosed acute and chronic cases of hepatitis B and C each year.
Why baby boomers need a hepatitis C screening
Hepatitis C affects a disproportionate amount of older Americans, born between 1945 and 1965.
Counterattack of the hepatitis B virus
The hepatitis B virus (HBV) infects liver cells. Drugs are available to treat HBV, but they rarely cure the infection, and so the virus typically returns after the treatment ends.
Hepatitis C tied to increased risk of Parkinson's
The hepatitis C virus may be associated with an increased risk of developing Parkinson's disease, according to a study published in the Dec.
The hepatitis A virus is of animal origin
The hepatitis A virus can trigger acute liver inflammation which generally has a mild course in small children but which can become dangerous in adults.
Modeling the helicase to understand hepatitis C
NS3 is an enzyme specific to the hepatitis C virus.

Related Hepatitis Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...